Avantor (NYSE:AVTR) Receives “Outperform” Rating from Royal Bank of Canada

Royal Bank of Canada reiterated their outperform rating on shares of Avantor (NYSE:AVTR) in a report published on Thursday, Benzinga reports. The firm currently has a $34.00 price objective on the stock.

Several other research analysts have also issued reports on AVTR. Robert W. Baird raised their price target on shares of Avantor from $26.00 to $27.00 and gave the stock an outperform rating in a report on Monday, July 29th. Wells Fargo & Company initiated coverage on shares of Avantor in a research report on Tuesday, August 27th. They issued an overweight rating and a $30.00 price target for the company. Barclays lifted their price target on shares of Avantor from $25.00 to $28.00 and gave the company an overweight rating in a research report on Monday, July 29th. TD Cowen lifted their price objective on shares of Avantor from $28.00 to $31.00 and gave the stock a buy rating in a report on Monday, July 29th. Finally, Stifel Nicolaus boosted their price target on shares of Avantor from $27.00 to $28.00 and gave the stock a buy rating in a report on Monday, July 29th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of Moderate Buy and a consensus price target of $28.00.

Avantor Trading Down 0.9 %

Shares of Avantor stock opened at $25.83 on Thursday. The company has a market capitalization of $17.55 billion, a price-to-earnings ratio of 66.23, a PEG ratio of 2.71 and a beta of 1.32. The company has a quick ratio of 1.05, a current ratio of 1.59 and a debt-to-equity ratio of 0.89. Avantor has a 12-month low of $16.63 and a 12-month high of $28.00. The firm’s 50-day moving average price is $25.55 and its two-hundred day moving average price is $24.37.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. Avantor had a net margin of 5.28% and a return on equity of 12.40%. The company had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.70 billion. On average, analysts forecast that Avantor will post 1.01 earnings per share for the current fiscal year.

Insider Activity

In other news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the sale, the chief accounting officer now directly owns 29,544 shares in the company, valued at $740,372.64. The sale was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of AVTR. Versant Capital Management Inc increased its position in shares of Avantor by 2,003.6% in the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after purchasing an additional 1,102 shares during the last quarter. Blue Trust Inc. raised its holdings in shares of Avantor by 1,830.3% during the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after acquiring an additional 1,391 shares in the last quarter. TFO Wealth Partners LLC raised its holdings in shares of Avantor by 203,100.0% during the fourth quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock valued at $46,000 after acquiring an additional 2,031 shares in the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH bought a new position in shares of Avantor during the first quarter valued at approximately $93,000. Finally, ORG Partners LLC raised its holdings in shares of Avantor by 5,773.0% during the second quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock valued at $122,000 after acquiring an additional 5,773 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.